Search

Search Constraints

You searched for: Subject multiple sclerosis -- NMDA

Search Results

1. Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis. Issue 1 (18th May 2021)

2. Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis. Issue 1 (18th May 2021)